Andlauer Healthcare Gr Stock EBITDA
| AND Stock | CAD 42.80 0.16 0.38% |
Andlauer Healthcare Gr fundamentals help investors to digest information that contributes to Andlauer Healthcare's financial success or failures. It also enables traders to predict the movement of Andlauer Stock. The fundamental analysis module provides a way to measure Andlauer Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Andlauer Healthcare stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 164.2 M | 108.1 M |
Andlauer | EBITDA |
Andlauer Healthcare Gr Company EBITDA Analysis
Andlauer Healthcare's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Andlauer Healthcare EBITDA | 164.2 M |
Most of Andlauer Healthcare's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Andlauer Healthcare Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Andlauer EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Andlauer Healthcare is extremely important. It helps to project a fair market value of Andlauer Stock properly, considering its historical fundamentals such as EBITDA. Since Andlauer Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Andlauer Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Andlauer Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Andlauer Ebitda
Ebitda |
|
According to the company disclosure, Andlauer Healthcare Gr reported earnings before interest,tax, depreciation and amortization of 164.2 M. This is 71.81% lower than that of the Air Freight & Logistics sector and significantly higher than that of the Industrials industry. The ebitda for all Canada stocks is 95.79% higher than that of the company.
Andlauer EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Andlauer Healthcare's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Andlauer Healthcare could also be used in its relative valuation, which is a method of valuing Andlauer Healthcare by comparing valuation metrics of similar companies.Andlauer Healthcare is currently under evaluation in ebitda category among its peers.
Andlauer Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0883 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 1.8 B | ||||
| Shares Outstanding | 18.48 M | ||||
| Shares Owned By Insiders | 1.82 % | ||||
| Shares Owned By Institutions | 69.89 % | ||||
| Number Of Shares Shorted | 48.02 K | ||||
| Price To Earning | 52.63 X | ||||
| Price To Book | 4.14 X | ||||
| Price To Sales | 2.58 X | ||||
| Revenue | 647.95 M | ||||
| Gross Profit | 223.3 M | ||||
| EBITDA | 164.2 M | ||||
| Net Income | 66.14 M | ||||
| Cash And Equivalents | 65.86 M | ||||
| Cash Per Share | 0.70 X | ||||
| Total Debt | 127.9 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.55 X | ||||
| Book Value Per Share | 10.29 X | ||||
| Cash Flow From Operations | 104.42 M | ||||
| Short Ratio | 2.27 X | ||||
| Earnings Per Share | 1.58 X | ||||
| Target Price | 47.5 | ||||
| Number Of Employees | 2.29 K | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 1.68 B | ||||
| Total Asset | 682.43 M | ||||
| Retained Earnings | (269.72 M) | ||||
| Working Capital | 105.62 M | ||||
| Current Asset | 263 M | ||||
| Current Liabilities | 13 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 682.43 M | ||||
| Last Dividend Paid | 0.4 |
About Andlauer Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Andlauer Healthcare Gr's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Andlauer Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Andlauer Healthcare Gr based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Andlauer Stock
Andlauer Healthcare financial ratios help investors to determine whether Andlauer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Andlauer with respect to the benefits of owning Andlauer Healthcare security.